Professional Documents
Culture Documents
PHARMACEUTICAL SCIENCES
http://doi.org/10.5281/zenodo.1067101
Please cite this article in press as Ali Kasiri and Hesam Hedayati., The Effect of Topical Bevacizumab on
Corneal Neovasularization in a Rabbit Model, Indo Am. J. P. Sci, 2017; 4[11].
respectively. Also at the 2 week after treatment weeks treatment. The mean percentage of changes
were 61.45 6.18 and 84.96 5.21 respectively of corneal neovascularization area in bevacizumab
(Table-1). After 1 week treatment, the and saline groups were 38.556.18 and 15.045.21
neovascularization area in bevacizumab group was respectively (Table-2).
regressed more than saline group significantly The mean percentage of regression of corneal
( P<0.0001) (Figure-2). After 2 week treatment, neovascularization area in bevacizumab group were
the neovascularization area in bevacizumab groups different to saline group significantly (P<0.0001)
was regressed more than salin group significantly (Figure-3).
(P<0.0001) (Figure-2). Figure-3 showed the
changes of corneal neovascularization area in two
Bevacizumab 38.556.18
Fig 1: Comparison the meanSD between two groups after 1 & 2 weeks
1.2
0.8
0.6
0.4
0.2
0
1 week 2 weeks